Acorn Creek Capital LLC reduced its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 18.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,644 shares of the company’s stock after selling 365 shares during the period. Acorn Creek Capital LLC’s holdings in Procter & Gamble were worth $262,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Nova Wealth Management Inc. acquired a new position in shares of Procter & Gamble in the first quarter worth approximately $26,000. Signature Resources Capital Management LLC lifted its stake in shares of Procter & Gamble by 67.9% in the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after acquiring an additional 72 shares during the period. Quarry LP acquired a new position in Procter & Gamble in the first quarter valued at approximately $33,000. Mizuho Securities Co. Ltd. lifted its stake in Procter & Gamble by 566.7% in the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock valued at $34,000 after buying an additional 170 shares during the period. Finally, RMG Wealth Management LLC acquired a new position in Procter & Gamble in the second quarter valued at approximately $37,000. 65.77% of the stock is owned by institutional investors and hedge funds.
Procter & Gamble Stock Performance
NYSE:PG opened at $149.69 on Monday. The business’s 50-day moving average price is $155.24 and its two-hundred day moving average price is $159.41. Procter & Gamble Company has a twelve month low of $149.45 and a twelve month high of $180.43. The stock has a market cap of $350.34 billion, a P/E ratio of 22.99, a PEG ratio of 3.97 and a beta of 0.36. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49.
Insider Activity
In other news, COO Shailesh Jejurikar sold 13,039 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the transaction, the chief operating officer directly owned 28,036 shares in the company, valued at approximately $4,409,221.72. This represents a 31.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Marc S. Pritchard sold 9,849 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,548,952.23. Following the transaction, the insider owned 182,422 shares in the company, valued at $28,689,507.94. This trade represents a 5.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
PG has been the topic of several recent analyst reports. Wells Fargo & Company dropped their price target on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research note on Thursday, September 25th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Procter & Gamble in a report on Wednesday, October 8th. Evercore ISI reiterated an “in-line” rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. BNP Paribas Exane reduced their price objective on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research note on Tuesday, September 23rd. Finally, Bank of America dropped their price target on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Eleven investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $172.21.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
- Five stocks we like better than Procter & Gamble
- How to start investing in penny stocks
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- Using the MarketBeat Dividend Yield Calculator
- Could Target’s Week of Discounts Come Full Circle for Investors?
- Insider Trading – What You Need to Know
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.